Ben Kuen Chen

Ben Kuen Chen


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Oncogene
Verified
Journal Article
Open access
YLY-H Liao
Y-H Liao
KCK-H Chiang
K-H Chiang
JSJ-M Shieh
J-M Shieh
CHC-R Huang
C-R Huang
CSC-J Shen
C-J Shen
BCBen Kuen Chen
Ben Kuen Chen
Epidermal growth factor (EGF) is important for cancer cell proliferation, angiogenesis and metastasis in many types of cancer. However, the mechanisms involved in EGF-induced head and neck squamous cell carcinoma (HNSCC) metastasis remain largely unknown. In this study, we reveal that angiopoietin-like 4 (ANGPTL4) plays an important role in the regulation of EGF-induced cancer metastasis. We showed that EGF-induced ANGPTL4 expression promoted anoikis resistance and cancer cell migration and invasion in HNSCC. In addition, depletion of ANGPTL4 inhibited EGF-induced cancer cell invasion. Autocrine production of EGF-induced ANGPTL4 regulated the expression of matrix metalloproteinases (MMPs). The induction of MMP-1 gene expression by ANGPTL4-activated integrin β1 signalling occurred through the AP-1 binding site in the MMP-1 gene promoter. Furthermore, down-regulation of MMP-1 impeded EGF- and recombinant ANGPTL4-enhanced HNSCC cell migration and invasion. Depletion of ANGPTL4 significantly blocked EGF-primed extravasation and metastatic seeding of tumour cells and MMP-1 expression in lungs. However, no effect of ANGPTL4 on tumour growth was observed. These results suggest that EGF-induced expression and autocrine production of ANGPTL4 enhances HNSCC metastasis via the up-regulation of MMP-1 expression. Inhibition of ANGPTL4 expression may be a potential strategy for the treatment of EGFR-mediated HNSCC metastasis.

8 March 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
Wei-Chiao ChangWei-Chiao Chang
Wei-Chiao Chang
SWShuo-Lun Wu
Shuo-Lun Wu
WHWan-Chen Huang
Wan-Chen Huang
JHJinn-Yuan Hsu
Jinn-Yuan Hsu
SCShih-Hung Chan
Shih-Hung Chan
BCBen Kuen Chen
Ben Kuen Chen
Overexpression of the epidermal growth factor (EGF) receptor (EGFR) is associated with enhanced invasion and metastasis in head and neck squamous cell carcinoma (HNSCC). Long Pentraxin PTX3 is involved in immune escape in cancer cells. Here, we identified PTX3 as a promoting factor that mediates EGF-induced HNSCC metastasis. EGF-induced PTX3 transcriptional activation is via the binding of c-Jun to the activator protein (AP)-1 binding site of the PTX3 promoter. PI3K/Akt and NF-κB were essential for the PTX3 activation. EGF-induced PTX3 expression was blocked in c-Jun- and NF-κB-knockdown cells. EGF-mediated PTX3 secretion resulted in the enhancement of cell migration and invasion, and interactions between cancer and endothelial cells. The tail-vein injection animal model revealed that depletion of PTX3 decreased EGF-primed tumor cell metastatic seeding of the lungs. In addition, fibronectin, matrix metalloproteinase-9 (MMP9) and E-cadherin were essential components in EGFR/PTX3-mediated cancer metastasis. In conclusion, PI3K/Akt and NF-κB-dependent regulation of AP-1 mediates PTX3 transcriptional responses to EGF. Autocrine production of EGF-induced PTX3 in turn induces metastatic molecules, activating inflammatory cascades and metastasis.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
CSChih-Jie Shen
Chih-Jie Shen
KCKwang-Yu Chang
Kwang-Yu Chang
BLBo-Wen Lin
Bo-Wen Lin
WLWei-Ting Lin
Wei-Ting Lin
CSChe-Min Su
Che-Min Su
BCBen Kuen Chen
Ben Kuen Chen
Background: Colorectal cancer (CRC) progression and related mortality are highly associated with metabolic disorders. However, the molecular mechanism involved in the regulation of hyperlipidemia-associated CRC metastasis remains unclear. This study aimed to investigate the effects of angiopoietin-like 4 (ANGPTL4) on NADPH oxidase 4 (NOX4) expression and reactive oxygen species (ROS) production, which might provide new targets for improving outcomes in patients with hyperlipidemia-associated CRC metastasis.

1 February 2017 in Cancer Letters
Verified
Journal Article
Closed access
CSChih-Jie Shen
Chih-Jie Shen
SCShih-Hung Chan
Shih-Hung Chan
CLChung-Ta Lee
Chung-Ta Lee
WHWan-Chen Huang
Wan-Chen Huang
JTJhih-Peng Tsai
Jhih-Peng Tsai
BCBen Kuen Chen
Ben Kuen Chen

20 March 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
CHChi-Ruei Huang
Chi-Ruei Huang
CLChung-Ta Lee
Chung-Ta Lee
KCKwang-Yu Chang
Kwang-Yu Chang
WCWen-Chang Chang
Wen-Chang Chang
YLYao-Wen Liu
Yao-Wen Liu
BCBen Kuen Chen
Ben Kuen Chen
Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis

13 November 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
JTJen-Hui Tsou
Jen-Hui Tsou
KCK.-Y. Chang
K.-Y. Chang
WWW.-C. Wang
W.-C. Wang
JTJ. T. Tseng
J. T. Tseng
Wu-Chou  SuWu-Chou Su
Wu-Chou Su
BCBen Kuen Chen
Ben Kuen Chen
The expression of cPLA2 is critical for transformed growth of non-small cell lung cancer (NSCLC). It is known that phorbol 12-myristate 13-acetate (PMA)-activated signal transduction pathway is thought to be involved in the oncogene action in NSCLC and enzymatic activation of cPLA2. However, the transcriptional regulation of cPLA2alpha in PMA-activated NSCLC is not clear. In this study, we found that PMA induced the mRNA level and protein expression of cPLA2alpha. In addition, two Sp1-binding sites of cPLA2alpha promoter were required for response to PMA and c-Jun overexpression. Small interfering RNA (siRNA) of c-Jun and nucleolin inhibited PMA induced the promoter activity and protein expression of cPLA2alpha. Furthermore, PMA stimulated the formation of c-Jun/Sp1 and c-Jun/nucleolin complexes as well as the binding of these transcription factor complexes to the cPLA2alpha promoter. Although Sp1-binding sites were required for the bindings of Sp1 and nucleolin to the promoter, the binding of nucleolin or Sp1 to the promoter was independent of each other. Our results revealed that c-Jun/nucleolin and c-Jun/Sp1 complexes play an important role in PMA-regulated cPLA2alpha gene expression. It is likely that nucleolin binding at place of Sp1 on gene promoter could also mediate the regulation of c-Jun/Sp1-activated genes.